E Fund Management Co., Ltd. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q4 2022$125
-99.9%
24,706
-11.1%
0.01%
-23.1%
Q3 2022$138,000
+7.8%
27,804
+21.9%
0.01%
+225.0%
Q1 2022$128,000
+42.2%
22,816
+53.3%
0.00%
+33.3%
Q4 2021$90,000
-26.8%
14,883
+17.8%
0.00%
-40.0%
Q3 2021$123,00012,6380.01%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders